The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia

Matthew J. Reesa Department of Clinical Haematology, Austin Health, Melbourne, AustraliaCorrespondence[email protected]

https://orcid.org/0000-0001-8360-2952

Simon Wub Department of Clinical Haematology, Eastern Health, Melbourne, Australia

Mridula Mokoonlallc Department of Clinical Haematology, Canberra Hospital, Canberra, Australia

Caroline H. K. Dixd Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia

Christian E. Bryantd Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia

James D’Rozarioc Department of Clinical Haematology, Canberra Hospital, Canberra, Australia

Anthony Schwarera Department of Clinical Haematology, Austin Health, Melbourne, Australia;b Department of Clinical Haematology, Eastern Health, Melbourne, Australia

Andrew Grigga Department of Clinical Haematology, Austin Health, Melbourne, Australia

Ing Soo Tionga Department of Clinical Haematology, Austin Health, Melbourne, Australia

show all

Click to increase image sizeClick to decrease image size

Disclosure statement

The authors report no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia

Information for

Open access

Opportunities

Help and information

The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature